Siren »

Caribou Biosciences shares owned by Siren

Quarter-by-quarter ownership of Caribou Biosciences (CRBU) shares owned by Siren from 13F filings

Historical chart of Siren investment in Caribou Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Caribou Biosciences held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caribou Biosciences by Siren

Quarter filed Position value Share count Share price at filing
2024-09-30 $207k 105k 1.96

More positions owned by Siren

Kymera Therapeutics (KYMR)
Beigene Sponsored Adr (BGNE)
Scholar Rock Hldg Corp (SRRK)
Bicara Therapeutics
Argenx SE Sponsored Adr (ARGX)
Crinetics Pharmaceuticals In (CRNX)
Avidity Biosciences Ord (RNA)
Apellis Pharmaceuticals (APLS)
Lexicon Pharmaceuticals Com New (LXRX)
Igm Biosciences (IGMS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Silence Therapeutics Ads (SLN)
Arrowhead Pharmaceuticals (ARWR)
WAVE Life Sciences SHS (WVE)

View all positions for Siren

Top funds holding Caribou Biosciences

BlackRock
BlackRock
Bank of America Corporation
Vanguard Group
Partner Fund Management
Point72 Asset Management
Elmwood Wealth Management
Dimensional Fund Advisors
Geode Capital Management
Kynam Capital Management
Schonfeld Strategic Advisors
State Street Corporation
Goldman Sachs Group
Two Sigma Investments
Two Sigma Advisers

View all funds holding Caribou Biosciences